Sample menu:
Organization |  |
The NIRM knowledge program brings together the scientific expertise of stem cell and tissue engineering research laboratories throughout the Netherlands. The integrated work covers both fundamental and applied research and is referred to as "regenerative medicine". More than 50 internationally renowned Dutch scientists are involved. The combined efforts of these scientists together with related industry are expected to lead to exciting outcomes beyond those already achieved from the earlier research programs, SCDD and DPTE.
NIRM aims to advance biomedical technology and applications in human health and disease. In addition, through new international collaborations (such as the California Institute for Regenerative Medicine, Harvard Institute for Regenerative Medicine, and others), NIRM intends to build the knowledge base concerning the elements needed for the long-term success of regenerative medicine. Our close association with major academic medical centers, Biomedical Materials Program (BMM), National Genomics Initiative (NGI), Center for Translational Molecular Medicine (CTMM) and industry will facilitate bundling of scientific knowledge into implementation of stem cells, molecular reagents, (epi)genetic diagnostic tests, preclinical models and therapeutic strategies for clinical interventions providing economic benefit for the Netherlands.
The combined expertise within NIRM matches the 'Build – Bundle – Benefit' framework of Life Sciences & Health , the initiative of the Dutch government to help boost life science and healthcare innovations. A framework based on three pillars:
- Building top quality research infrastructure
- Bundling top research groups in academia and industry
- Providing an environment in which researchers can benefit from new knowledge